SPONSOR
University Hospital Heidelberg
Total Trials
10
Recruiting
10
Phases
Phase 2, Phase 3, Phase 1, Phase 2, Phase 2
Conditions studied: Metastatic Colorectal CancerCNS TumorSolid TumorPatients With Brain Masses/LesionsInterstitial Lung Diseases (ILD)Low Grade GliomaSarcoma,Soft TissueMeningiomaHepatic MetastasisOsteoarthritis
University Hospital Heidelberg is a clinical research sponsor with 10 registered studies on ClinicalTrials.gov, of which 10 are actively recruiting participants. Research covers conditions including Metastatic Colorectal Cancer, CNS Tumor, Solid Tumor, Patients With Brain Masses/Lesions.
The trial portfolio spans Phase 2, Phase 3, Phase 1, Phase 2, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — University Hospital Heidelberg
How many clinical trials has University Hospital Heidelberg sponsored?
ClinicalMetric currently tracks 10 clinical trials sponsored by University Hospital Heidelberg, of which 10 are actively recruiting participants. These trials cover conditions including Metastatic Colorectal Cancer, CNS Tumor, Solid Tumor. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University Hospital Heidelberg research focus on?
University Hospital Heidelberg clinical trials span Metastatic Colorectal Cancer, CNS Tumor, Solid Tumor, Patients With Brain Masses/Lesions, Interstitial Lung Diseases (ILD), and additional conditions. The research pipeline includes Phase 2, Phase 3, Phase 1, Phase 2, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University Hospital Heidelberg clinical trial?
To participate in a University Hospital Heidelberg trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University Hospital Heidelberg trials with current recruitment status updated daily.
Clinical Trials by University Hospital Heidelberg
NCT06243393 Phase 2, Phase 3
Recruiting
Sacituzumab Govitecan in Metastatic Colorectal Cancer
Metastatic Colorectal Cancer
NCT03838042 Phase 1, Phase 2
Recruiting
INFORM2 Study Uses Nivolumab and Entinostat in Children and Adolescents With High-risk Refractory Malignancies
CNS Tumor
NCT06401057
Recruiting
Register for Longitudinal Recording of Brain Function
Patients With Brain Masses/Lesions
NCT07300696
Recruiting
Functional MRI for Monitoring Progression and Assessing Trends in ILD
Interstitial Lung Diseases (ILD)
NCT05964569 Phase 2
Recruiting
Feasibility of Individualized, Model-guided Optimization of Proton Beam Treatment Planning in Patients With Low Grade Glioma
Low Grade Glioma
NCT04219202
Recruiting
Neoadjuvant Irradiation of Retroperitoneal Soft Tissue Sarcoma With Ions Retro-Ion
Sarcoma,Soft Tissue
NCT06104930
Recruiting
Plasma Extracellular Vesicles in Meningioma Patients
Meningioma
NCT05027711 Phase 2
Recruiting
Magnetic Resonance-guided Adaptive Stereotactic Body Radiotherapy for Hepatic Metastases
Hepatic Metastasis
NCT06850818
Recruiting
Heidelberg Registry for Hip and Knee Joint Implants and Revisions
Osteoarthritis
NCT06360328
Recruiting
Success Rates of Video- vs. Direct Laryngoscopy for Endotracheal Intubation in Anesthesiology Residents: A Randomized Controlled Trial" (The JuniorDoc-VL-Trial)
Intubation Complication
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology